1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. Issue 10 (30th June 2016) Authors: Anderson, Peter M.; Bielack, Stefan S.; Gorlick, Richard G.; Skubitz, Keith; Daw, Najat C.; Herzog, Cynthia E.; Monge, Odd R.; Lassaletta, Alvaro; Boldrini, Erica; Pápai, Zsuzanna; Rubino, Joseph; Pathiraja, Kumudu; Hille, Darcy A.; Ayers, Mark; Yao, Siu‐Long; Nebozhyn, Michael; Lu, Brian; Mauro,... Journal: Pediatric blood & cancer Issue: Volume 63:Issue 10(2016) Page Start: 1761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial. Issue 2 (17th October 2016) Authors: Sclafani, Francesco; Kim, Tae Y.; Cunningham, David; Kim, Tae W.; Tabernero, Josep; Schmoll, Hans J.; Roh, Jae K.; Kim, Sun Y.; Park, Young S.; Guren, Tormod K.; Hawkes, Eliza; Clarke, Stephen J.; Ferry, David; Frodin, Jan‐Erik; Ayers, Mark; Nebozhyn, Michael; Peckitt, Clare; Loboda, Andrey; Watk... Journal: International journal of cancer Issue: Volume 140:Issue 2(2017:Jan. 15) Page Start: 431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preclinical to clinical translation of anti-PD-1 blockade. (4th November 2015) Authors: Hirsch, Heather; Pinheiro, Elaine; Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Cai, Mingmei; Ma, Yanhong; Sathe, Manjiri; McClanahan, Terri Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Preclinical to clinical translation of anti-PD-1 blockade. Issue 2 (December 2015) Authors: Hirsch, Heather; Pinheiro, Elaine; Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Cai, Mingmei; Ma, Yanhong; Sathe, Manjiri; McClanahan, Terri Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors. (4th November 2015) Authors: Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Loboda, Andrey; Albright, Andrew; Cheng, Jonathan; Kang, S Peter; Ebbinghaus, Scot; Yearley, Jennifer; Shankaran, Veena; Seiwert, Tanguy; Ribas, Antoni; McClanahan, Terri Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors. Issue 2 (December 2015) Authors: Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Loboda, Andrey; Albright, Andrew; Cheng, Jonathan; Kang, S; Ebbinghaus, Scot; Yearley, Jennifer; Shankaran, Veena; Seiwert, Tanguy; Ribas, Antoni; McClanahan, Terri Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗